Signaturefd, LLC Relmada Therapeutics, Inc. Transaction History

Signaturefd, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$18.3 - $37.02 $1,189 - $2,406	65 Added 30.52%	278 $10,000
Q2 2022 Aug 10, 2022	SELL	$16.5 - $30.34 $82 - $151	-5 Reduced 2.29%	213 $4,000
Q1 2022 May 02, 2022	BUY	$16.72 - $26.99 $1,805 - $2,914	108 Added 98.18%	218 $6,000
Q4 2021 Jan 25, 2022	BUY	$16.93 - $26.82 $1,862 - $2,950	110 New	110 $2,000

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $79M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.